With BioFlux System for live cell analysis under shear flow and IsoFlux System for circulating tumor cell analysis, Fluxion Biosciences turn power of benchtop cellular analysis with advanced tools to automate complex assays.
Accelerate to discover
Back to filter
Show all topics (10)
Related topics
Cytek LIVE Demo : introducing the new Autofluorescence (AF) Explorer in Spectroflo 3.2.1
Sep 25, 2023
In this webinar, Cytek will be covering the new features introduced in the newest SpectroFlo 3.2.1 software release and...
Educational webinar: Introducing MARS Platform for gentle cell separation
Sep 6, 2023
Join us for a webinar where we will introduce the new MARS Platform by Applied Cells, a...
Meet us in Prague this weekend (2.-5.9) at 12th International Conference of Analytical Cytometry
Aug 29, 2023
Meet ACCELA team at 12th International Conference of Analytical Cytometry 2.-5.9.2023 in Prague,
Aug 17, 2023
Register for an engaging webinar led by Naz Chaudary, Ph.D., and Research Technician, Alex Wang from the...
Optimizing Gene Expression with Bioluminescence & the piggyBac System
Aug 15, 2023
Discover how bioluminescence imaging & the piggyBac gene editing system optimize & track gene expression in mouse...
Cytek webinar: High Parameter Spectral Flow Cytometry for Tumor Immunology Research
Jul 28, 2023
High Parameter Spectral Flow Cytometry for Tumor Immunology Research: This webinar will be a guide for Designing,...
High speed, compact and fully automated microscope inside your incubator? Lumascope850
Jul 13, 2023
The powerful, new LS850 Microscope is the latest generation of our fully automated three-channel flagship model and...
Webinar: Exploring Oncology applications with the WOLF G2 Cell Sorter and N1 Single-Cell Dispenser
Jun 19, 2023
This educational webinar invites you to explore the scientific capabilities and oncology applications of the...
Bioflux webinar: Blockade of CD62L inhibits CLL cell interaction with vascular endothelium
Nov 22, 2018
Researchers developed an assay to measure CLL cell interactions with endothelium under shear force using a Bioflux 200 and blocked CD62L using the anti-CD62L antibody DREG-56. CLL cell interactions with endothelium were visualized by time-lapse microscopy and CLL cell movement was tracked and quantified. Data will be discussed in the webinar and will establish targeting CD62L inhibits CLL cell/endothelial cell interactions and is accentuated by co-administration with ibrutinib. These data imply that some of the clinical effects caused by ibrutinib are due to a reduced capacity of CLL cells to engage endothelium and extravasate.
Dr. Chris Pepper, Professor in Cancer Studies, University of Sussex, UK
Related technologies: Cell interaction studies
Get more info
Brand profile
